Circularis Biotechnologies

📍 Oakland, United States🗓 Founded 2014👥 4 employees💰 Last funded 2021
Biotechnology Research🌐 circularisbiotech.com
Website LinkedIn
Control of any Gene in any Species or Cell Type Circularis has used the power of circular RNA to develop a novel method to study and regulate gene expression. This technology has enabled increased bio-therapeutic production, improved targeting of gene therapy, and optimized expression in poorly studied organisms. The elegant design and high throughput nature of this technology enables breakthrough solutions without prior knowledge of the regulatory elements or coding sequence.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Circularis Biotechnologies?
Circularis Biotechnologies has 2 investors on record on gritt.io and 2 late-stage investors.
When did Circularis Biotechnologies last raise funding?
The most recent investment in Circularis Biotechnologies recorded on gritt.io was in 2021.
When was Circularis Biotechnologies founded?
Circularis Biotechnologies was founded in 2014.
What industry is Circularis Biotechnologies in?
Circularis Biotechnologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Circularis Biotechnologies based?
Circularis Biotechnologies is headquartered in Oakland, United States.